Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
University Health Network, Toronto
University of California, Irvine
Qingdao Sino-Cell Biomedicine Co., Ltd.
Immatics US, Inc.
Acepodia Biotech, Inc.
BioEclipse Therapeutics
Gilead Sciences
Fate Therapeutics
Fate Therapeutics
Fate Therapeutics
H. Lee Moffitt Cancer Center and Research Institute
Fate Therapeutics
BGI, China
Genocea Biosciences, Inc.
GlaxoSmithKline
Guangzhou Institute of Respiratory Disease
Shenzhen Second People's Hospital